• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9 编辑的三重融合报告基因成像技术用于移植的人尿液诱导多能干细胞衍生心肌细胞的动态和功能研究。

CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes.

机构信息

Department of Nuclear Medicine and PET-CT Center, The Second Hospital, Zhejiang University School of Medicine, Zhejiang, 310009, Hangzhou, China.

Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Zhejiang, 310009, Hangzhou, China.

出版信息

Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):708-720. doi: 10.1007/s00259-020-05087-0. Epub 2020 Nov 20.

DOI:10.1007/s00259-020-05087-0
PMID:33216174
Abstract

PURPOSE

To investigate the post-transplantation behaviour and therapeutic efficacy of human urinary-induced pluripotent stem cell-derived cardiomyocytes (hUiCMs) in infarcted heart.

METHODS

We used clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9 (CRISPR/Cas9) technology to integrate a triple-fusion (TF) reporter gene into the AAVS1 locus in human urine-derived hiPSCs (hUiPSCs) to generate TF-hUiPSCs that stably expressed monomeric red fluorescent protein for fluorescence imaging, firefly luciferase for bioluminescence imaging (BLI) and herpes simplex virus thymidine kinase for positron emission tomography (PET) imaging.

RESULTS

Transplanted cardiomyocytes derived from TF-hUiPSCs (TF-hUiCMs) engrafted and proliferated in the infarcted heart as monitored by both BLI and PET imaging and significantly improved cardiac function. Under ischaemic conditions, TF-hUiCMs enhanced cardiomyocyte (CM) glucose metabolism and promoted angiogenic activity.

CONCLUSION

This study established a CRISPR/Cas9-mediated multimodality reporter gene imaging system that can determine the dynamics and function of TF-hUiCMs in myocardial infarction, which is helpful for investigating the application of stem cell therapy.

摘要

目的

研究人尿源性诱导多能干细胞衍生的心肌细胞(hUiCMs)在梗死心脏中的移植后行为和治疗效果。

方法

我们使用成簇规律间隔短回文重复序列/CRISPR 相关核酸酶 9(CRISPR/Cas9)技术将一个三重融合(TF)报告基因整合到人尿源性 hiPSC(hUiPSC)的 AAVS1 基因座中,生成稳定表达单体红色荧光蛋白的 TF-hUiPSC,用于荧光成像、萤火虫荧光素酶用于生物发光成像(BLI)和单纯疱疹病毒胸苷激酶用于正电子发射断层扫描(PET)成像。

结果

移植的来源于 TF-hUiPSC(TF-hUiCMs)的心肌细胞在梗死心脏中植入和增殖,通过 BLI 和 PET 成像监测,并显著改善了心脏功能。在缺血条件下,TF-hUiCMs 增强了心肌细胞(CM)的葡萄糖代谢并促进了血管生成活性。

结论

本研究建立了一种 CRISPR/Cas9 介导的多模态报告基因成像系统,可确定 TF-hUiCMs 在心肌梗死中的动态和功能,有助于研究干细胞治疗的应用。

相似文献

1
CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes.CRISPR/Cas9 编辑的三重融合报告基因成像技术用于移植的人尿液诱导多能干细胞衍生心肌细胞的动态和功能研究。
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):708-720. doi: 10.1007/s00259-020-05087-0. Epub 2020 Nov 20.
2
The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.人生长抑素受体 2 作为一种成像和自杀报告基因,用于多能干细胞衍生治疗心肌梗死。
Theranostics. 2018 Apr 14;8(10):2799-2813. doi: 10.7150/thno.22980. eCollection 2018.
3
Human induced pluripotent stem cell line with genetically encoded fluorescent voltage indicator generated via CRISPR for action potential assessment post-cardiogenesis.通过 CRISPR 生成具有遗传编码荧光电压指示剂的人诱导多能干细胞系,用于心肌发生后评估动作电位。
Stem Cells. 2020 Jan;38(1):90-101. doi: 10.1002/stem.3085. Epub 2019 Sep 30.
4
Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.利用 CRISPR-Cas9 系统对血友病 B 患者来源的诱导多能干细胞进行靶向基因组编辑。
Stem Cell Res Ther. 2018 Apr 6;9(1):92. doi: 10.1186/s13287-018-0839-8.
5
Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing.利用 CRISPR-Cas9 基因组编辑技术生成两个 ISL1-tdTomato 报告基因人诱导多能干细胞系。
Stem Cell Res. 2021 May;53:102363. doi: 10.1016/j.scr.2021.102363. Epub 2021 Apr 22.
6
Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation.用于持续内源性基因激活的纯合CRISPRa人类诱导多能干细胞(hiPSC)系的生成。
Stem Cell Res. 2020 Oct;48:101944. doi: 10.1016/j.scr.2020.101944. Epub 2020 Aug 14.
7
CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.CRISPR/Cas9 基因组编辑:诱导多能干细胞治疗应用的有前途的工具。
Curr Stem Cell Res Ther. 2018;13(4):243-251. doi: 10.2174/1574888X13666180214124800.
8
Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.通过CRISPR/Cas9系统生成的人诱导多能干细胞NEUROG2双敲入报告基因系
Stem Cells Dev. 2015 Dec 15;24(24):2925-42. doi: 10.1089/scd.2015.0131. Epub 2015 Nov 5.
9
Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.利用锌指核酸酶对人类胚胎干细胞和诱导多能干细胞进行基因组编辑,用于细胞成像。
Circ Res. 2012 Dec 7;111(12):1494-503. doi: 10.1161/CIRCRESAHA.112.274969. Epub 2012 Sep 11.
10
Increased Cytotoxicity of Herpes Simplex Virus Thymidine Kinase Expression in Human Induced Pluripotent Stem Cells.人诱导多能干细胞中单纯疱疹病毒胸苷激酶表达的细胞毒性增加。
Int J Mol Sci. 2019 Feb 14;20(4):810. doi: 10.3390/ijms20040810.

引用本文的文献

1
Global clinical trials on stem cell therapy for autoimmune diseases: trends and future directions.全球自身免疫性疾病干细胞治疗临床试验:趋势与未来方向
Front Immunol. 2025 Jul 24;16:1616231. doi: 10.3389/fimmu.2025.1616231. eCollection 2025.
2
Forebrain neural progenitors effectively integrate into host brain circuits and improve neural function after ischemic stroke.前脑神经祖细胞可有效整合到宿主脑回路中,并在缺血性中风后改善神经功能。
Nat Commun. 2025 Jun 3;16(1):5132. doi: 10.1038/s41467-025-60187-5.
3
Future direction: molecular imaging-based stem cell research.

本文引用的文献

1
Moving iPSC-Derived Cardiomyocytes Forward to Treat Myocardial Infarction.将诱导多能干细胞衍生的心肌细胞推向治疗心肌梗死。
Cell Stem Cell. 2018 Sep 6;23(3):322-323. doi: 10.1016/j.stem.2018.08.011.
2
Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates.人类胚胎干细胞衍生的心肌细胞可恢复非人灵长类动物梗死心脏的功能。
Nat Biotechnol. 2018 Aug;36(7):597-605. doi: 10.1038/nbt.4162. Epub 2018 Jul 2.
3
Therapeutic approaches for cardiac regeneration and repair.心脏再生和修复的治疗方法。
未来方向:基于分子成像的干细胞研究。
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1614-1617. doi: 10.1007/s00259-025-07067-8.
4
Application prospects of urine-derived stem cells in neurological and musculoskeletal diseases.尿液来源干细胞在神经和肌肉骨骼疾病中的应用前景。
World J Orthop. 2024 Oct 18;15(10):918-931. doi: 10.5312/wjo.v15.i10.918.
5
Reporter Alleles in hiPSCs: Visual Cues on Development and Disease.Reporter 人诱导多能干细胞中的等位基因:发育和疾病的视觉线索。
Int J Mol Sci. 2024 Oct 13;25(20):11009. doi: 10.3390/ijms252011009.
6
Positron emission tomography probes for stem cell monitoring: a review.用于干细胞监测的正电子发射断层扫描探针:综述
Am J Transl Res. 2024 Aug 15;16(8):3534-3544. doi: 10.62347/CIUT6327. eCollection 2024.
7
Urine-derived stem cells: Promising advancements and applications in regenerative medicine and beyond.尿液来源的干细胞:再生医学及其他领域的前景进展与应用
Heliyon. 2024 Mar 10;10(6):e27306. doi: 10.1016/j.heliyon.2024.e27306. eCollection 2024 Mar 30.
8
Induced Pluripotent Stem Cell-Derived Cardiomyocytes Therapy for Ischemic Heart Disease in Animal Model: A Meta-Analysis.诱导多能干细胞衍生的心肌细胞治疗动物模型缺血性心脏病的Meta 分析。
Int J Mol Sci. 2024 Jan 12;25(2):987. doi: 10.3390/ijms25020987.
9
Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit.CRISPR 工具包在干细胞基因组编辑中的研究与治疗方法。
Molecules. 2023 Feb 20;28(4):1982. doi: 10.3390/molecules28041982.
10
Genome Editing and Cardiac Regeneration.基因组编辑与心脏再生
Adv Exp Med Biol. 2023;1396:37-52. doi: 10.1007/978-981-19-5642-3_3.
Nat Rev Cardiol. 2018 Oct;15(10):585-600. doi: 10.1038/s41569-018-0036-6.
4
CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.CCND2 过表达增强了人诱导多能干细胞衍生心肌细胞的再生能力:损伤心室的再肌化。
Circ Res. 2018 Jan 5;122(1):88-96. doi: 10.1161/CIRCRESAHA.117.311504. Epub 2017 Oct 10.
5
MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.心肌缺血再灌注损伤后,定居心肌巨噬细胞上的MerTK裂解会损害修复。
Circ Res. 2017 Sep 29;121(8):930-940. doi: 10.1161/CIRCRESAHA.117.311327. Epub 2017 Aug 29.
6
Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.多能干细胞衍生的心肌细胞的旁分泌作用挽救受损心肌。
Circ Res. 2017 Sep 1;121(6):e22-e36. doi: 10.1161/CIRCRESAHA.117.310803. Epub 2017 Jul 25.
7
Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics.心肌梗死后的心脏再生和修复:新型治疗方法的转化机会。
Nat Rev Drug Discov. 2017 Oct;16(10):699-717. doi: 10.1038/nrd.2017.106. Epub 2017 Jul 21.
8
Metabolic Regulation of Apoptosis in Cancer.癌症中细胞凋亡的代谢调控
Int Rev Cell Mol Biol. 2016;327:43-87. doi: 10.1016/bs.ircmb.2016.06.006. Epub 2016 Jul 30.
9
In Vivo Dynamic Metabolic Changes After Transplantation of Induced Pluripotent Stem Cells for Ischemic Injury.诱导多能干细胞移植治疗缺血性损伤后的体内动态代谢变化
J Nucl Med. 2016 Dec;57(12):2012-2015. doi: 10.2967/jnumed.115.171124. Epub 2016 Aug 25.
10
Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.成人干细胞治疗与心力衰竭:2000 年至 2016 年的系统评价。
JAMA Cardiol. 2016 Oct 1;1(7):831-841. doi: 10.1001/jamacardio.2016.2225.